TC BioPharm (Holdings) plc
TCBPDelisted Aug 8, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001872812
TC BioPharm (Holdings) plc was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Jan 11, 2023; 12 institutions reported holding it in 13F filings for Q3 2023, worth $179.6K in total; no superinvestor held it.
Q1 2025 vs. Q4 2024
How the institutions holding TC BioPharm (Holdings) plc changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 12 | 1 | −11 |
| Shares | 54.9K | 173 | −54.7K (−99.7%) |
| Value | $34.8K | $34 | −$34.8K (−99.9%) |
New holders (0)
Institutions that held TC BioPharm (Holdings) plc at the end of Q1 2025 but not at the end of Q4 2024.
None.
Sold out (11)
Institutions that held TC BioPharm (Holdings) plc at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Cubist Systematic Strategies, LLC | 15,553 | $10.0K |
| Virtu Financial LLC | 16,042 | $10.0K |
| HRT Financial LP | 14,316 | $9.00K |
| SBI Securities Co., Ltd. | 4,127 | $2.66K |
| JPMorgan Chase & Co | 1,679 | $1.08K |
| GAMMA Investing LLC | 1,225 | $790 |
| Harbour Investments, Inc. | 236 | $152 |
| New England Capital Financial Advisors LLC | 201 | $130 |
| Truvestments Capital LLC | 200 | $129 |
| Wells Fargo & Company | 140 | $90 |
| Toth Financial Advisory Corp | 30 | $20 |